LEG
53
-4
APH
61
2
AIG
56
2
BXP
62
2
SHW
59
-3
PYPL
41
-13
MMM
52
-4
FRT
55
2
CSX
57
13
NWS
78
-2
CVS
61
-3
MET
48
-2
OMC
51
-3
MTCH
55
-7
AVB
42
-2
HRL
38
-7
LEN
44
-4
FTI
78
17
HPE
66
-7
PFG
43
-3
LEG
53
-4
APH
61
2
AIG
56
2
BXP
62
2
SHW
59
-3
PYPL
41
-13
MMM
52
-4
FRT
55
2
CSX
57
13
NWS
78
-2
CVS
61
-3
MET
48
-2
OMC
51
-3
MTCH
55
-7
AVB
42
-2
HRL
38
-7
LEN
44
-4
FTI
78
17
HPE
66
-7
PFG
43
-3
Financhill
Back

Intrepid Potash 10K Form

Sell
50

IPI
Intrepid Potash

Last Price:
$34.79
Seasonality Move:
-5.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IPI News And Ratings

See the #1 stock for the next 7 days that we like better than IPI

IPI Financial Statistics

Sales & Book Value

Annual Sales: $254.7M
Cash Flow: $2.6M
Price / Cash Flow: 71.29
Annual Sales: $36.99
Price / Book: 0.97

Profitability

EPS (TTM): -15.89000
Net Income (TTM): $-205.1M
Gross Margin: $29.1M
Return on Equity: -34.2%
Return on Assets: -28.48%

Intrepid Potash Earnings Forecast

Key Intrepid Potash Financial Ratios

  • The Gross Profit Margin over the past 19 years for IPI is 11.42%.
  • The Selling, General & Administrative Expenses for IPI have been equal to 12.94% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Net Earning history of IPI is -83.57% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 7 years.

Intrepid Potash Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Chemicals
Sector: Materials
Current Symbol: IPI
CUSIP: 46121Y
Website: intrepidpotash.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.17
Quick Ratio: 2.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IPI Technical Analysis vs Fundamental Analysis

Sell
50
Intrepid Potash (IPI) is a Sell

Is Intrepid Potash a Buy or a Sell?

  • Intrepid Potash stock is rated a Sell
    The current Intrepid Potash [IPI] share price is $35.10. The Score for IPI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.